FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 201 through 250 of 335

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
MOLN Nasdaq Molecular Partners AG 2836
MRKR Nasdaq Marker Therapeutics, Inc. 2836
MRNA Nasdaq Moderna, Inc. 2836
MRSN Nasdaq Mersana Therapeutics, Inc. 2836
MYNZ Nasdaq Mainz Biomed N.V. 2836
NCNA Nasdaq NuCana plc 2836
NEUP Nasdaq Neuphoria Therapeutics Inc. 2836
NGNE Nasdaq Neurogene Inc. 2836
NNVC NYSE American NanoViricides, Inc. 2836
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2836
NTLA Nasdaq Intellia Therapeutics, Inc. 2836
NTRA Nasdaq Natera, Inc. 2836
NUVB New York Nuvation Bio Inc. 2836
NUVL Nasdaq Nuvalent, Inc. 2836
OABI Nasdaq OmniAb, Inc. 2836
OCEA Nasdaq Ocean Biomedical, Inc. 2836
OCGN Nasdaq Ocugen, Inc. 2836
OCX Nasdaq OncoCyte Corporation 2836
OGEN NYSE American Oragenics, Inc. 2836
OKYO Nasdaq OKYO Pharma Limited 2836
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2836
ONC Nasdaq BeiGene, Ltd. 2836
ONCO Nasdaq Onconetix, Inc. 2836
ONVO Nasdaq Organovo Holdings, Inc. 2836
ORGS Over the counter Orgenesis Inc. 2836
ORIC Nasdaq ORIC Pharmaceuticals, Inc. 2836
ORKA Nasdaq Oruka Therapeutics, Inc. 2836
OTLK Nasdaq Outlook Therapeutics, Inc. 2836
OVID Nasdaq Ovid Therapeutics Inc. 2836
PACB Nasdaq Pacific Biosciences of California, Inc. 2836
PALI Nasdaq Palisade Bio, Inc. 2836
PBYI Nasdaq Puma Biotechnology, Inc. 2836
PEPG Nasdaq PepGen Inc. 2836
PFE New York Pfizer Inc. 2836
PGEN Nasdaq Precigen, Inc. 2836
PHAR Nasdaq Pharming Group N.V. 2836
PHGE NYSE American BiomX Inc. 2836
PLUR Nasdaq Pluri Inc. 2836
PLX NYSE American Protalix BioTherapeutics, Inc. 2836
PMCB Nasdaq PharmaCyte Biotech, Inc. 2836
POAI Nasdaq Predictive Oncology Inc. 2836
PRLD Nasdaq Prelude Therapeutics Incorporated 2836
PRME Nasdaq Prime Medicine, Inc. 2836
PROK Nasdaq ProKidney Corp. 2836
PRQR Nasdaq ProQR Therapeutics N.V. 2836
PRTA Nasdaq Prothena Corporation plc 2836
PSTV Nasdaq Plus Therapeutics, Inc. 2836
PTIX Nasdaq Protagenic Therapeutics, Inc. 2836
PTN NYSE American Palatin Technologies, Inc. 2836
PVLA Nasdaq Palvella Therapeutics, Inc. 2836
Results 200 through 250 of 335